Life Sciences
The aim is to provide AI-powered cancer risk prediction and independent report generation to help clinicians detect cancer.
The deal boosts GE HealthCare's pharma diagnostics sector and signifies its dedication to molecular imaging.
The aim is to provide long-term behavioral change focusing on weight loss and maintenance.
Elon Musk's Neuralink gets greenlit by Health Canada to perform the first trial outside of the U.S. of its brain-computer implant and robot technology.
The money will be used to develop new medications and biologicals.
OneCell Diagnostics scores $16 million for genomics-based precision oncology and dannce.ai, a phenotyping platform to digitize clinical assessments, secures $2.6 million.
The company will use the funds to drive product development, strategic account management and market growth.
Quinn digital marketing manager Deo Jimenez says they are building on Singaporeans' growing openness to discussing sexual health.
Around two in five Malaysians are said to have metabolic syndrome.
The aim is to reduce processing times, increase workflow and improve accuracy in medical records evaluations.